Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Prostatic Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Myasthenia Gravis 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Lung Neoplasms 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Abortion, Spontaneous 2

Interventions

Serum Albumin 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Intestinal Neuroendocrine Tumor × Data Collection × Clear all

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡